| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Clindamycin phosphate |
Is a |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin palmitate hydrochloride |
Is a |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin hydrochloride |
Is a |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin measurement |
Component |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin adverse reaction |
Causative agent (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to clindamycin (finding) |
Causative agent (attribute) |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin 1% roll-on lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin 1% topical alcoholic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing clindamycin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing clindamycin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin 75mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin 10mg/mL gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 150mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 600mg/4mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 300mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 150mg/mL injection solution 6mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 10mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 600mg/bag solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 300mg/50mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 900mg/50mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 2% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 300mg/50mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 600mg/50mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 900mg/50mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 100mg vaginal ovule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 10mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 150mg/mL injection solution 4mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Cleocin t 10mg/ml lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 150mg/ml injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin 1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Product containing clindamycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin phosphate 900mg/6ml injection solution 6mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin 2% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 150mg/mL injection solution 4 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 2% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate 20 mg/mL vaginal cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin hydrochloride 75mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin hydrochloride 150mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| clindamycine 600 mg/4 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin 1% topical foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Product containing benzoyl peroxide and clindamycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely benzoyl peroxide 50 milligram/1 gram and clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Product containing clindamycin in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing clindamycin and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Benzoyl peroxide 2.5% + clindamycin 1.2% topical gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin 1.2%/tretinoin 0.025% topical gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Allergy to clindamycin (finding) |
Causative agent (attribute) |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin (as clindamycin hydrochloride) 75 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely clindamycin (as clindamycin phosphate) 100 milligram/1 each conventional release vaginal pessary (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin palmitate hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Clindamycin phosphate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely benzoyl peroxide 50 milligram/1 gram and clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous lotion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely clindamycin (as clindamycin phosphate) 300 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely clindamycin (as clindamycin phosphate) 600 milligram/4 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing clindamycin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Benzoyl peroxide- and clindamycin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only clindamycin and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only benzoyl peroxide and clindamycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only clindamycin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only clindamycin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only clindamycin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin only product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Benzoyl peroxide and clindamycin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing clindamycin and tretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely clindamycin (as clindamycin hydrochloride) 300 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin (as clindamycin phosphate) 20 mg/g vaginal cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely clindamycin (as clindamycin phosphate) 6 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin (as clindamycin phosphate) 150 mg/mL solution for infusion and/or injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin (as clindamycin phosphate) 150 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous emulsion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clindamycin (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]